PubRank
Search
About
Masanori Hayami
Author PubWeight™ 30.03
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon.
J Gen Virol
2005
1.71
2
High prevalence of simian T-lymphotropic virus type L in wild ethiopian baboons.
J Virol
2002
1.09
3
Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection.
J Gen Virol
2006
1.08
4
Genetic origins of the Ainu inferred from combined DNA analyses of maternal and paternal lineages.
J Hum Genet
2004
1.01
5
Genetic diversity of HIV type 1 in rural eastern Cameroon.
J Acquir Immune Defic Syndr
2004
1.00
6
Three major lineages of Asian Y chromosomes: implications for the peopling of east and southeast Asia.
Hum Genet
2001
0.99
7
Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
J Med Virol
2004
0.91
8
Impaired T-cell differentiation in the thymus at the early stages of acute pathogenic chimeric simian-human immunodeficiency virus (SHIV) infection in contrast to less pathogenic SHIV infection.
Microbes Infect
2006
0.89
9
In vivo analysis of a new R5 tropic SHIV generated from the highly pathogenic SHIV-KS661, a derivative of SHIV-89.6.
Virology
2010
0.88
10
HIV type 1 infection in Pygmy hunter gatherers is from contact with Bantu rather than from nonhuman primates.
AIDS Res Hum Retroviruses
2003
0.88
11
Phylogenetic analysis of SIV derived from mandrill and drill.
Front Biosci
2004
0.87
12
Genetic diversity of HIV type 1 in Likasi, southeast of the Democratic Republic of Congo.
AIDS Res Hum Retroviruses
2004
0.87
13
Protection by intranasal immunization of a nef-deleted, nonpathogenic SHIV against intravaginal challenge with a heterologous pathogenic SHIV.
Virology
2002
0.86
14
Linkage of amino acid variation and evolution of human immunodeficiency virus type 1 gp120 envelope glycoprotein (subtype B) with usage of the second receptor.
J Mol Evol
2004
0.84
15
Contribution of monocytes to viral replication in macaques during acute infection with simian immunodeficiency virus.
AIDS Res Hum Retroviruses
2007
0.83
16
Construction and in vivo infection of a new simian/human immunodeficiency virus chimera containing the reverse transcriptase gene and the 3' half of the genomic region of human immunodeficiency virus type 1.
J Gen Virol
2003
0.83
17
Small intestine CD4+ T cells are profoundly depleted during acute simian-human immunodeficiency virus infection, regardless of viral pathogenicity.
J Virol
2008
0.82
18
A novel simian immunodeficiency virus from black mangabey (Lophocebus aterrimus) in the Democratic Republic of Congo.
J Gen Virol
2005
0.80
19
DNA vaccination of macaques by a full-genome simian/human immunodeficiency virus type 1 plasmid chimera that produces non-infectious virus particles.
J Gen Virol
2003
0.79
20
Genetic similarity of circulating and small intestinal virus at the end stage of acute pathogenic simian-human immunodeficiency virus infection.
Front Microbiol
2013
0.79
21
Comparative histopathological studies in the early stages of acute pathogenic and nonpathogenic SHIV-infected lymphoid organs.
Virology
2003
0.79
22
DNA vaccination of macaques by a full-genome SHIV plasmid that has an IL-2 gene and produces non-infectious virus particles.
Vaccine
2005
0.78
23
Intrathymic effect of acute pathogenic SHIV infection on T-lineage cells in newborn macaques.
Microbiol Immunol
2005
0.78
24
Infection of a chimeric simian and human immunodeficiency virus with CCR5-specific HIV-1 envelope to Rhesus macaques.
J Vet Med Sci
2003
0.78
25
Early virological events in various tissues of newborn monkeys after intrarectal infection with pathogenic simian human immunodeficiency virus.
J Med Primatol
2005
0.78
26
Phylogenetic heterogeneity of new HTLV type 1 isolates from southern India in subgroup A.
AIDS Res Hum Retroviruses
2005
0.78
27
Mutational analysis of two zinc-finger motifs in the nucleocapsid protein of simian immunodeficiency virus mac239.
J Gen Virol
2003
0.77
28
Induction of immune response in macaque monkeys infected with simian-human immunodeficiency virus having the TNF-alpha gene at an early stage of infection.
Virology
2005
0.77
29
Construction of a novel SHIV having an HIV-1-derived protease gene and its infection to rhesus macaques: a useful tool for in vivo efficacy tests of protease inhibitors.
Microbes Infect
2007
0.77
30
Construction and in vitro properties of chimeric simian and human immunodeficiency virus with the human TNF-alpha gene.
Microbiol Immunol
2002
0.77
31
Genetic subtypes of HIV type 1 based on the vpu/env sequences in the Republic of Congo.
AIDS Res Hum Retroviruses
2002
0.77
32
A genetically engineered live-attenuated simian-human immunodeficiency virus that co-expresses the RANTES gene improves the magnitude of cellular immunity in rhesus macaques.
Virology
2006
0.76
33
Small intestine CD4+ cell reduction and enteropathy in simian/human immunodeficiency virus KS661-infected rhesus macaques in the presence of low viral load.
J Gen Virol
2009
0.76
34
Construction and infection of a new simian/human immunodeficiency chimeric virus (SHIV) containing the integrase gene of the human immunodeficiency virus type 1 genome and analysis of its adaptation to monkey cells.
Microbes Infect
2008
0.76
35
Analysis of a primary isolate-like virus from simian and human immunodeficiency virus-infected macaque having broad neutralizing activity.
AIDS Res Hum Retroviruses
2002
0.75
36
Co-expression of interleukin-5 influences replication of simian/human immunodeficiency viruses in vivo.
J Gen Virol
2002
0.75
37
Construction and in vitro characterization of a chimeric simian and human immunodeficiency virus with the RANTES gene.
Microbes Infect
2005
0.75
38
The impact of highly active antiretroviral therapy by the oral route on the CD8 subset in monkeys infected chronically with SHIV 89.6P.
J Virol Methods
2003
0.75
39
Protective efficacy of nonpathogenic nef-deleted SHIV vaccination combined with recombinant IFN-gamma administration against a pathogenic SHIV challenge in rhesus monkeys.
Microbiol Immunol
2005
0.75
40
Whole genome sequence data of an infectious molecular clone of the SIVagm TYO-1 strain.
AIDS Res Hum Retroviruses
2006
0.75
41
Characterization of vpr vector constructed from chimeric simian and human immunodeficiency virus.
J Vet Med Sci
2003
0.75